Skip to main content

Moderna CEO defends price increase for COVID vaccine to Congress

A hearing focused on Moderna’s plan to raise the price of its COVID-19 vaccine raised longstanding questions about how drugs should be priced in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.